Clinical Trial Detail

NCT ID NCT02122185
Title Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

ovarian carcinoma

peritoneal carcinoma

fallopian tube carcinoma

Therapies

Metformin

Carboplatin + Docetaxel + Paclitaxel

Age Groups: adult senior

No variant requirements are available.